Previous Section
Review Articles
11. Targeted chronic myeloid leukemia therapy: Seeking a cure.
- Author
- Fausel C;
- Institution
- Hematology/Oncology/BMT, Indiana University Cancer Center, 550 North University Boulevard, Indianapolis, IN 46202, USA. cfausel@clarian.org
- Journal
- Am J Health Syst Pharm. 2007 Dec 15;64(24 Suppl 15):S9-15.
- Abstract URL
- Click here to view abstract
12. Chronic myeloid leukemia in 2007.
- Author
- Sessions J;
- Institution
- Hematology/Oncology, Emory University Hospital, 1364 Clifton Road, NE, Atlanta, GA 30322, USA. jolynn_sessions@emoryhealthcare.org
- Journal
- Am J Health Syst Pharm. 2007 Dec 15;64(24 Suppl 15):S4-9.
- Abstract URL
- Click here to view abstract
13. New strategies in controlling drug resistance in chronic myeloid leukemia.
- Author
- Frame D;
- Institution
- Department of Pharmacy, University of Michigan, 1500 Medical Center Drive, Ann Arbor, MI 48109, USA. dframe@med.umich.edu
- Journal
- Am J Health Syst Pharm. 2007 Dec 15;64(24 Suppl 15):S16-21.
- Abstract URL
- Click here to view abstract
14. Part II: management of resistance to imatinib in chronic myeloid leukaemia.
- Author
- Apperley JF;
- Institution
- Department of Haematology, Imperial College, Hammersmith Hospital, London, UK. j.apperley@imperial.ac.uk
- Journal
- Lancet Oncol. 2007 Dec;8(12):1116-28.
- Abstract URL
- Click here to view abstract
15. State-of-the-art in the treatment of chronic myeloid leukaemia.
- Author
- Milojkovic D; Apperley J;
- Institution
- Department of Haematology, The Hammersmith Hospital, London, UK. d.milojkovic@imperial.ac.uk
- Journal
- Curr Opin Oncol. 2008 Jan;20(1):112-21.
- Abstract URL
- Click here to view abstract
16. Current perspectives on the treatment of patients with chronic myeloid leukemia: an individualized approach to treatment.
- Author
- Jabbour E; Cortes J; Giles F; Kantarjian H;
- Institution
- Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.
- Journal
- Cancer J. 2007 Nov-Dec;13(6):357-65.
- Abstract URL
- Click here to view abstract
17. Management of Bcr-Abl-positive leukemias with dasatinib.
- Author
- Hochhaus A;
- Institution
- III. Medizinische Klinik, Abteilung Leukaemieforschung, Medizinische Fakultaet Mannheim, University of Heidelberg, 68167 Mannheim, Germany. hochhaus@uni-hd.de
- Journal
- Expert Rev Anticancer Ther. 2007 Nov;7(11):1529-36.
- Abstract URL
- Click here to view abstract
18. Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.
- Author
- Steinberg M;
- Institution
- Department of Pharmacy Practice, Massachusetts College of Pharmacy and Health Sciences, 19 Foster Street, Worcester, MA 01608, USA. michael.steinberg@mcphs.edu
- Journal
- Clin Ther. 2007 Nov;29(11):2289-308.
- Abstract URL
- Click here to view abstract
19. Treatment for chronic myelogenous leukemia: the long road to imatinib.
- Author
- Hunter T;
- Institution
- Molecular and Cell Biology Laboratory, Salk Institute for Biological Studies, La Jolla, California 92037-1099, USA. hunter@salk.edu
- Journal
- J Clin Invest. 2007 Aug;117(8):2036-43.
- Abstract URL
- Click here to view abstract
20. Chronic myeloid leukaemia.
- Author
- Hehlmann R; Hochhaus A; Baccarani M;
- Institution
- III Medizinische Universitatsklinik, Medizinische Fakultat Mannheim der Universitat Heidelberg, Mannheim, Germany. Ruediger.Hehlmann@med3.ma.uni-heidelberg.de
- Journal
- Lancet. 2007 Jul 28;370(9584):342-50.
- Abstract URL
- Click here to view abstract
